MultivisionDx
Helsinki
About MultivisionDx
MultivisionDx's computer vision technology integrates the tumor's unique biological and geographical properties, as well as its milieu, to generate patient-specific tumor profiles.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Pre-Seed (Dec 2025)
- Website: multivision.ai
- Phone: [email protected]
Industries & Categories
Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/multivisiondx-45591 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.